ArticleJAMA otolaryngology-- head & neck surgery2015

Mitigation of Tumor-Associated Fibroblast-Facilitated Head and Neck Cancer Progression With Anti-Hepatocyte Growth Factor Antibody Ficlatuzumab.

Dhruv Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.